Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies-authors' response

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 4, 2011, Pages 955-

  Alanio, A ^a   Cordonnier, C ^a,b   Bretagne, S ^a,b,c  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c INSTITUT PASTEUR   (France)

Author keywords

Antimicrobial resistance surveillance; Aspergillus spp.; Azole antifungals

Indexed keywords

CYP51A; CYTOCHROME; ITRACONAZOLE; PYRROLE; UNCLASSIFIED DRUG; VORICONAZOLE;

ANTIFUNGAL RESISTANCE; ASPERGILLUS FUMIGATUS; FUNGUS ISOLATION; HEMATOLOGIC MALIGNANCY; HUMAN; LETTER; MUTATION; NONHUMAN;

EID: 79952797186     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr022     Document Type: Letter

References (5)

1. Verweij PE, Camps SMT, Kema GHJ et al. Comment on: Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies. J Antimicrob Chemother 2011; 66: 954-955.
2. Alanio A, Sitterlé E, Liance M et al. Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies. J Antimicrob Chemother 2011; 66: 371-4.
3. Leroux P, Albertini C, Gautier A et al. Mutations in the CYP51 gene correlated with changes in sensitivity to sterol 14a-demethylation inhibitors in field isolates of Mycosphaerella graminicola. Pest Manag Sci 2007; 63: 688-98.
4. Snelders E, van der Lee HAL, Kuijpers J et al. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med 2008; 5: e219.
5. Mortensen KL, Mellado E, Lass-Flö rl C et al. Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain. Antimicrob Agents Chemother 2010; 54: 4545-9.